AAAAAA

   
Results: 1-9 |
Results: 9
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer
Authors: Elisaf, MS Bairaktari, ET Nicolaides, C Kakaidi, B Tzallas, CS Katsaraki, A Pavlidis, NA
Citation: Ms. Elisaf et al., Effect of letrozole on the lipid profile in postmenopausal women with breast cancer, EUR J CANC, 37(12), 2001, pp. 1510-1513
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
Authors: Pectasides, D Aravantinos, G Kalofonos, H Kiamouris, C Bafaloukos, D Xiros, N Nicolaides, C Visvikis, A Dimopoulos, MA
Citation: D. Pectasides et al., Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 12(10), 2001, pp. 1417-1422
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas
Authors: Bai, M Vlachonikolis, J Agnantis, NJ Tsanou, E Dimou, S Nicolaides, C Stefanaki, S Pavlidis, N Kanavarous, P
Citation: M. Bai et al., Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas, MOD PATHOL, 14(11), 2001, pp. 1105-1113
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group
Authors: Pectasides, D Kalofonos, HP Samantas, E Nicolaides, C Papacostas, P Onyenadum, A Visvikis, A Skarlos, D Fountzilas, G
Citation: D. Pectasides et al., An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group, ANTICANC R, 21(4B), 2001, pp. 3005-3010
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Nicolaides, C Dimopoulos, MA Samantas, E Bafaloukos, D Kalofonos, C Fountzilas, G Razi, E Kosmidis, P Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875
Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study
Authors: Samantas, E Kalofonos, H Linardou, H Nicolaides, C Mylonakis, N Fountzilas, G Kosmidis, P Skarlos, D
Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study
Authors: Fountzilas, G Nicolaides, C Bafaloukos, D Kalogera-Fountzila, A Kalofonos, H Samelis, G Aravantinos, G Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Stathopoulos, G Nicolaides, C Kalogera-Fountzila, A Kalofonos, H Nikolaou, A Bacoyiannis, C Samantas, E Papadimitriou, C Kosmidis, P Daniilidis, J Pavlidis, N
Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478
Risultati: 1-9 |